Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Dexmedetomidine on Hemodynamic Response During Double Lumen Endotracheal Intubation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA Physical Status I-III~* Undergoing Elective Thoracotomy or Thoracoscopy~* Required Left Sided-double Lumen Endotracheal Intubation~Exclusion Criteria:~* Patients with bradycardia (heart rate \< 50 beat per minute) or heart block~* Suspected of Difficult Intubation~* Patients Who Are at Risk for Rapid Change of Hemodynamics~* Allergic to Dexmedetomidine~* Hepatic or Renal Impairment (Preoperative Serum Creatinine \> 1.5 mg/dl)~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- dexmedetomidine (Type: ACTIVE_COMPARATOR): None
- control (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).